Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Biogen Idec Accused Again of Excessive CEO Pay, Lousy Performance, By Big Shareholder
|
Luke Timmerman |
11/20/09 |
Boston
|
|
Tysabri, the MS Drug Haunted by Deadly Side Effect, Doesn’t Look So Deadly Anymore
|
Luke Timmerman |
11/19/09 |
Boston
|
|
Virdante Pharma Lands $30M in A Round to Combat Inflammation
|
Ryan McBride |
10/29/09 |
Boston
|
|
European Regulators Question Antigenics and Biogen Idec Drugs, BioAssets Bags $30M in Option Deal, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/28/09 |
Boston
|
|
Biogen Shares Drop as Tysabri PML Cases Climb to 23, Europe May Seek Drug ‘Holiday’
|
Luke Timmerman |
10/23/09 |
Boston
|
|
Seattle Biotech Needs More Bars, Less University Red Tape, and the Same Daring Attitude, & Other Highlights from Seattle Life Sciences 2029
|
Luke Timmerman |
10/21/09 |
Seattle
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Bigtime Biotech Thinkers Steven Burrill and Gary Pisano Agree on Bright Future of Industry, Disagree on How to Build Value
|
Ryan McBride |
10/08/09 |
Boston
|
|
DC Matters, But Biotech Can’t Neglect City Hall
|
David Miller |
10/07/09 |
Seattle
|
|
Ironwood Recruits Genentech, Facebook Star as Company Knocks on Wall Street Doors
|
Luke Timmerman |
10/05/09 |
Boston
|
|
Facet Board Recommends Rejecting Biogen Bid
|
Robert Buderi |
10/01/09 |
Boston
|
|
Alkermes’ Ambitious Builder, Richard Pops, Grabs Reins to Re-Ignite Growth Phase
|
Luke Timmerman |
09/28/09 |
Boston
|
|
A123Systems Pulls Off Big IPO, PrimeraDx Grabs $20M, Conduit Labs Collects $3M, and More Boston-Area Deals News
|
Rebecca Zacks |
09/25/09 |
Boston
|
|
Biogen Idec Still Pursuing Facet Acquisition, Helicos Gets $10M Reprieve, Seaside Collects $30M for Autism Drug Development, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/23/09 |
Boston
|
|
Biogen Tender Offer For Facet Begins
|
Rebecca Zacks |
09/21/09 |
Boston
|
|
Tysabri’s Tally of PML Cases Reaches 13
|
Luke Timmerman |
09/17/09 |
Boston
|
|
Federal Judge Rules in Biogen Idec’s Favor, Sepracor Agrees to $2.8B Buyout, FDA Panel Endorses Gloucester Pharma Drug, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/11/09 |
Boston
|
|
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Facet Rejects Biogen Takeover Bid
|
Luke Timmerman |
09/08/09 |
Boston
|
|
Sepracor Snatched up for $2.6B, EMC Acquires FastScale and Kazeon, Biogen Makes Bid For Facet, & More Boston-Area Deals News
|
Rebecca Zacks |
09/08/09 |
Boston
|
|
Biogen Idec Makes Hostile $350M Takeover Bid for Facet Biotech
|
Luke Timmerman |
09/04/09 |
Boston
|
|
Elan Breached Tysabri Partnership With Biogen Idec, Federal Judge Says
|
Luke Timmerman |
09/04/09 |
Boston
|
|
Pickett to Relinquish Biogen Idec Board Seat, New Financing for iWalk, Genocea Goes After Vaccine Market, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/02/09 |
Boston
|
|
Amylin and Biogen Idec Make Board Changes, Inovio Catches Wave of Investor ‘Swine Flu’ Fervor, Ligand Buys Neurogen, & Other San Diego Life Sciences News
|
Bruce V. Bigelow |
08/27/09 |
San Diego
|
|
Biogen Idec Research Boss Quits Board, Giving Icahn Shot at Pushing R&D Agenda
|
Luke Timmerman |
08/26/09 |
Boston
|
|
Another Biogen Director to Retire
|
Ryan McBride |
08/26/09 |
Boston
|
|
Intellikine, Stocked With Cash, Pushes Portfolio of Drugs Against Biology’s Hot Targets
|
Luke Timmerman |
08/18/09 |
San Diego
|
|
Biogen Idec Faces Suit From Partner Elan, Genzyme Wins European Approval for Stem-Cell Boosting Drug, Alnylam Teams with Tekmira, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
08/12/09 |
Boston
|
|
Elan Hits Biogen Idec with Lawsuit to Protect Tysabri Deal with J&J
|
Ryan McBride |
08/06/09 |
Boston
|
|
VC Biotech Funding Rebounds, Biogen Idec Co-Founder Resigns From Board, Pathway Genomics Debuts $250 Personal Genome Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
07/23/09 |
San Diego
|
|
Page 1 of
8 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
